114 related articles for article (PubMed ID: 15087241)
1. Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2004 Apr; 489(3):187-91. PubMed ID: 15087241
[TBL] [Abstract][Full Text] [Related]
2. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
[TBL] [Abstract][Full Text] [Related]
3. Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2005 Jun; 516(3):219-26. PubMed ID: 15963494
[TBL] [Abstract][Full Text] [Related]
4. Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Kato A; Koyama T
Eur J Pharmacol; 2005 Sep; 520(1-3):37-42. PubMed ID: 16153636
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
Page ME; Lucki I
Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597
[TBL] [Abstract][Full Text] [Related]
6. In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism.
Ortega JE; Fernández-Pastor B; Callado LF; Meana JJ
Eur Neuropsychopharmacol; 2010 Nov; 20(11):813-22. PubMed ID: 20813509
[TBL] [Abstract][Full Text] [Related]
7. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
Linnér L; Endersz H; Ohman D; Bengtsson F; Schalling M; Svensson TH
J Pharmacol Exp Ther; 2001 May; 297(2):540-6. PubMed ID: 11303041
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
Kitaichi Y; Inoue T; Nakagawa S; Boku S; Izumi T; Koyama T
Eur J Pharmacol; 2010 Jul; 637(1-3):77-82. PubMed ID: 20406628
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
[TBL] [Abstract][Full Text] [Related]
10. Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.
Invernizzi RW; Sacchetti G; Parini S; Acconcia S; Samanin R
Br J Pharmacol; 2003 Aug; 139(7):1281-8. PubMed ID: 12890707
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.
Invernizzi RW; Parini S; Sacchetti G; Fracasso C; Caccia S; Annoni K; Samanin R
Br J Pharmacol; 2001 Jan; 132(1):183-8. PubMed ID: 11156576
[TBL] [Abstract][Full Text] [Related]
12. Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex.
Nakamura S; Ago Y; Itoh S; Koyama Y; Baba A; Matsuda T
Eur J Pharmacol; 2005 Dec; 528(1-3):95-8. PubMed ID: 16321379
[TBL] [Abstract][Full Text] [Related]
13. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
Dekeyne A; Gobert A; Iob L; Cistarelli L; Melon C; Millan MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):213-8. PubMed ID: 11702096
[TBL] [Abstract][Full Text] [Related]
15. The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: a microdialysis study with freely moving rats.
Mizoguchi N; Saigusa T; Aono Y; Sekino R; Takada K; Oi Y; Ueda K; Koshikawa N; Cools AR
Eur J Pharmacol; 2008 Dec; 601(1-3):94-8. PubMed ID: 18996113
[TBL] [Abstract][Full Text] [Related]
16. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade.
Valentini V; Cacciapaglia F; Frau R; Di Chiara G
J Neurochem; 2006 Jul; 98(1):113-21. PubMed ID: 16805801
[TBL] [Abstract][Full Text] [Related]
17. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.
Sacchetti G; Bernini M; Bianchetti A; Parini S; Invernizzi RW; Samanin R
Br J Pharmacol; 1999 Nov; 128(6):1332-8. PubMed ID: 10578149
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW
Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex.
Hudson AL; Lalies MD; Silverstone P
Can J Physiol Pharmacol; 2012 Jun; 90(6):803-9. PubMed ID: 22512539
[TBL] [Abstract][Full Text] [Related]
20. Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus.
Parini S; Renoldi G; Battaglia A; Invernizzi RW
Neuropsychopharmacology; 2005 Jun; 30(6):1048-55. PubMed ID: 15668723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
